Filters
Topics
Campus & Community
Colleges & Schools

Picking up good vibrations – of proteins – at CHESS

A new method for analyzing protein crystals – developed by Cornell researchers and given a funky two-part name – could open up applications for new drug discovery and other areas of biotechnology and biochemistry.

Technology showcase returns with a BOOM

Bits On Our Minds technology showcase, held April 27 in the Duffield Hall atrium, featured cutting-edge technology projects from across the university.

Tobias Meyer elected to the American Academy of Arts and Sciences

Meyer is the Joseph C. Hinsey Professor in Cell and Developmental Biology at Weill Cornell Medicine.

HIV patients fare well with mpox treatment

Patients with HIV had similar treatment outcomes to patients without HIV when treated for mpox with an antiviral drug called tecovirimat, according to a new study.

Engineering, Weill Cornell Medicine pilot M.D.-M.Eng. degree

As part of a new cross-college initiative designed to accelerate engineering innovations in medicine, Cornell Engineering is piloting an M.D.-M.Eng. program that allows medical students at Weill Cornell Medicine to earn a one-year professional Master of Engineering degree.

Around Cornell

‘Phenomenal’ Dead & Co. concert awes a grateful crowd

The Big Red was awash in tie-dye May 8 as Dead & Company came to Barton Hall for a jubilant benefit show that had multiple generations celebrating the return of members of the Grateful Dead to the site of one of their most historic shows.

Prioritize space to dream, OADI alumna tells diverse students

An enthusiastic audience of 100 Cornellians celebrated academic achievements and community at the Office of Academic Diversity Initiatives’ annual Honors Award Ceremony on May 5.

$4.3M grant to develop farm of the future tech

Cutting-edge, data-driven agricultural technologies and precision management strategies designed for the farm of the future will be developed, evaluated and demonstrated, thanks to a four-year, $4.3 million U.S. Department of Agriculture grant.

Epigenetic drug aids chemotherapy in lymphoma study

Nearly 90% of patients with an aggressive subtype of non-Hodgkin lymphoma had their cancer go into remission in a small phase 2 clinical trial testing a treatment aimed at making chemotherapy more effective, according to Weill Cornell Medicine and NewYork-Presbyterian investigators.

Two from Cornell named HHMI Freeman Hrabowski Scholars

Two Cornell faculty members have been named Freeman Hrabowski Scholars by the Howard Hughes Medical Institute, in recognition of their potential to become leaders in their research fields and to create diverse and inclusive lab environments.

Hospital-at-home programs lack standards, accountability

More research and oversight are needed before making permanent a pandemic policy that allows hospitals to treat acutely ill patients in their homes, according to new Cornell research.

Alum’s software helps teachers know what’s working in the classroom

The next episode of Startup Cornell features Nona Ullman ‘88, an entrepreneur creating software to help teachers.

Around Cornell